183 related articles for article (PubMed ID: 24964702)
21. Measurement of health outcomes.
Thavorncharoensap M
J Med Assoc Thai; 2014 May; 97 Suppl 5():S27-32. PubMed ID: 24964696
[TBL] [Abstract][Full Text] [Related]
22. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.
Husereau D; Drummond M; Petrou S; Carswell C; Moher D; Greenberg D; Augustovski F; Briggs AH; Mauskopf J; Loder E;
Value Health; 2013; 16(2):231-50. PubMed ID: 23538175
[TBL] [Abstract][Full Text] [Related]
23. Defining the scope of economic evaluation study and selection of comparators.
Chaiyakunapruk N
J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S16-20. PubMed ID: 19253484
[TBL] [Abstract][Full Text] [Related]
24. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.
Husereau D; Drummond M; Petrou S; Carswell C; Moher D; Greenberg D; Augustovski F; Briggs AH; Mauskopf J; Loder E;
Value Health; 2013; 16(2):e1-5. PubMed ID: 23538200
[TBL] [Abstract][Full Text] [Related]
25. Making health technology assessment information available for decision making: the development of a Thai database.
Kapol N; Maitreemit P; Chalongsuk R; Amrumpai Y; Sribundit N; Thavorncharoensap M; Chaikledkaew U; Teerawattananon Y
J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S8-10. PubMed ID: 19253482
[TBL] [Abstract][Full Text] [Related]
26. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.
Sullivan SD; Mauskopf JA; Augustovski F; Jaime Caro J; Lee KM; Minchin M; Orlewska E; Penna P; Rodriguez Barrios JM; Shau WY
Value Health; 2014; 17(1):5-14. PubMed ID: 24438712
[TBL] [Abstract][Full Text] [Related]
27. Strengthening cost-effectiveness analysis in Thailand through the establishment of the health intervention and technology assessment program.
Tantivess S; Teerawattananon Y; Mills A
Pharmacoeconomics; 2009; 27(11):931-45. PubMed ID: 19888793
[TBL] [Abstract][Full Text] [Related]
28. Optimal decision rules for HTA under uncertainty: a wider, dynamic perspective.
Forster M; Pertile P
Health Econ; 2013 Dec; 22(12):1507-14. PubMed ID: 23225192
[TBL] [Abstract][Full Text] [Related]
29. A review of cost-effectiveness evaluations as part of national health technology assessments of biologic DMARDs in the treatment of rheumatoid arthritis.
Iannazzo S; De Francesco M; Gomez-Ulloa D; Benucci M
Expert Rev Pharmacoecon Outcomes Res; 2013 Aug; 13(4):455-68. PubMed ID: 23977974
[TBL] [Abstract][Full Text] [Related]
30. The greatest happiness of the greatest number? Policy actors' perspectives on the limits of economic evaluation as a tool for informing health care coverage decisions in Thailand.
Teerawattananon Y; Russell S
BMC Health Serv Res; 2008 Sep; 8():197. PubMed ID: 18817579
[TBL] [Abstract][Full Text] [Related]
31. Social and ethical analysis in health technology assessment.
Tantivess S
J Med Assoc Thai; 2014 May; 97 Suppl 5():S81-6. PubMed ID: 24964703
[TBL] [Abstract][Full Text] [Related]
32. [HEALTH ECONOMIC ANALYSIS AND FAIR DECISION MAKING].
Jeantet M; Lopez A
Rev Prat; 2015 Sep; 65(7):909-11. PubMed ID: 26619723
[TBL] [Abstract][Full Text] [Related]
33. An introduction to the methods of cost-effectiveness analysis.
Drug Ther Bull; 2012 Jul; 50(7):81-4. PubMed ID: 22789768
[TBL] [Abstract][Full Text] [Related]
34. Modelling in the economic evaluation of health care: selecting the appropriate approach.
Barton P; Bryan S; Robinson S
J Health Serv Res Policy; 2004 Apr; 9(2):110-8. PubMed ID: 15099459
[TBL] [Abstract][Full Text] [Related]
35. Economic evaluation.
Drummond MF; Aguiar-Ibanez R; Nixon J
Singapore Med J; 2006 Jun; 47(6):456-61; quiz 462. PubMed ID: 16752012
[TBL] [Abstract][Full Text] [Related]
36. [Economic evaluations more and more important in healthcare decision making. Costs must be balanced against benefits also in studies on health economics].
Lundkvist J
Lakartidningen; 2006 Nov 15-21; 103(46):3624-7. PubMed ID: 17153872
[No Abstract] [Full Text] [Related]
37. Measurement of clinical effects.
Teerawattananon Y; Thavorncharoensap M; Mohara A
J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S38-42. PubMed ID: 19253486
[TBL] [Abstract][Full Text] [Related]
38. Increasing the generalizability of economic evaluations: recommendations for the design, analysis, and reporting of studies.
Drummond M; Manca A; Sculpher M
Int J Technol Assess Health Care; 2005; 21(2):165-71. PubMed ID: 15921055
[TBL] [Abstract][Full Text] [Related]
39. Historical development of health technology assessment in Thailand.
Teerawattananon Y; Tantivess S; Yothasamut J; Kingkaew P; Chaisiri K
Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():241-52. PubMed ID: 19527543
[TBL] [Abstract][Full Text] [Related]
40. Economic evaluations conducted by Canadian health technology assessment agencies: where do we stand?
Tarride JE; McCarron CE; Lim M; Bowen JM; Blackhouse G; Hopkins R; O'Reilly D; Xie F; Goeree R
Int J Technol Assess Health Care; 2008; 24(4):437-44. PubMed ID: 18828938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
